BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 30991632)

  • 1. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
    Raimondo S; Giavaresi G; Lorico A; Alessandro R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
    Ingato D; Lee JU; Sim SJ; Kwon YJ
    J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milk-derived Extracellular Vesicles for Therapeutic Delivery of Small Interfering RNAs.
    Matsuda A; Patel T
    Methods Mol Biol; 2018; 1740():187-197. PubMed ID: 29388145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles from Plants: Current Knowledge and Open Questions.
    Urzì O; Raimondo S; Alessandro R
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk of Nanosystems Induced Extracellular Vesicles as Promising Tools in Biomedical Applications.
    Harisa GI; Badran MM; Alanazi FK; Attia SM
    J Membr Biol; 2017 Dec; 250(6):605-616. PubMed ID: 29127486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems.
    Piffoux M; Silva AKA; Wilhelm C; Gazeau F; Tareste D
    ACS Nano; 2018 Jul; 12(7):6830-6842. PubMed ID: 29975503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-Derived Extracellular Vesicles as Therapeutic Nanocarriers.
    Karamanidou T; Tsouknidas A
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.
    Liu C; Gao H; Lv P; Liu J; Liu G
    Hum Vaccin Immunother; 2017 Nov; 13(11):2678-2687. PubMed ID: 28949786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant-derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications.
    Lian MQ; Chng WH; Liang J; Yeo HQ; Lee CK; Belaid M; Tollemeto M; Wacker MG; Czarny B; Pastorin G
    J Extracell Vesicles; 2022 Dec; 11(12):e12283. PubMed ID: 36519808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Inflammatory Vasculature by Extracellular Vesicles.
    Wang S; Dong X; Gao J; Wang Z
    AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.
    O'Loughlin AJ; Mäger I; de Jong OG; Varela MA; Schiffelers RM; El Andaloussi S; Wood MJA; Vader P
    Mol Ther; 2017 Jul; 25(7):1580-1587. PubMed ID: 28392161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities.
    Lu M; Xing H; Yang Z; Sun Y; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Biopharm; 2017 Oct; 119():381-395. PubMed ID: 28739288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loading of Extracellular Vesicles with Hydrophobically Modified siRNAs.
    Didiot MC; Haraszti RA; Aronin N; Khvorova A
    Methods Mol Biol; 2018; 1740():199-214. PubMed ID: 29388146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
    Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.